These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811 [TBL] [Abstract][Full Text] [Related]
25. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Agustí AG; Villaverde JM; Togores B; Bosch M Eur Respir J; 1999 Sep; 14(3):523-8. PubMed ID: 10543270 [TBL] [Abstract][Full Text] [Related]
26. [Fractional exhaled nitric oxide in bronchial inflammatory lung diseases]. Xia Q; Pan P; Wang Z; Lu R; Hu C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 39(4):365-70. PubMed ID: 24820276 [TBL] [Abstract][Full Text] [Related]
28. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Rutgers SR; van der Mark TW; Coers W; Moshage H; Timens W; Kauffman HF; Koëter GH; Postma DS Thorax; 1999 Jul; 54(7):576-80. PubMed ID: 10377200 [TBL] [Abstract][Full Text] [Related]
29. Comparison of fractional exhaled nitric oxide levels in chronic obstructive pulmonary disease, bronchial asthma and healthy subjects of Nepal. Shrestha SK; Shrestha S; Sharma L; Pant S; Neopane A J Breath Res; 2017 Sep; 11(4):047101. PubMed ID: 28686173 [TBL] [Abstract][Full Text] [Related]
30. [Determination and clinical implication of leukotriene B(4) and tumor necrosis factor-alpha in condensate of exhaled breath of chronic obstructive pulmonary disease patients]. Chen JL; Chen JR; Tao YJ; Cai YY; Tao GH Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jun; 20(6):357-60. PubMed ID: 18549718 [TBL] [Abstract][Full Text] [Related]
34. Relationship between exhaled nitric oxide and the frequency of severe acute exacerbation of COPD: 3-year follow-up. Antus B; Barta I Acta Physiol Hung; 2013 Dec; 100(4):469-77. PubMed ID: 24013942 [TBL] [Abstract][Full Text] [Related]
36. Hydrogen sulfide as a novel biomarker of asthma and chronic obstructive pulmonary disease. Suzuki Y; Saito J; Munakata M; Shibata Y Allergol Int; 2021 Apr; 70(2):181-189. PubMed ID: 33214087 [TBL] [Abstract][Full Text] [Related]
37. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study. Antus B; Barta I; Kullmann T; Lazar Z; Valyon M; Horvath I; Csiszer E Am J Respir Crit Care Med; 2010 Dec; 182(12):1492-7. PubMed ID: 20656939 [TBL] [Abstract][Full Text] [Related]
38. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H; Luo H; Chen P; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [TBL] [Abstract][Full Text] [Related]
39. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Paredi P; Kharitonov SA; Leak D; Ward S; Cramer D; Barnes PJ Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):369-73. PubMed ID: 10934055 [TBL] [Abstract][Full Text] [Related]
40. [The expression and implications of human alpha-defensin 1-3 in serum and induced sputum in patients with chronic obstructive pulmonary disease]. Wang Z; Yao WZ; Xia GG; Sun DJ Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):410-3. PubMed ID: 19031798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]